Long-Term Disease Control During Continuous Treatment with Upadacitinib and Baricitinib for Moderate-to-Severe Atopic Dermatitis: a Real-World Monocentric Retrospective Study.
D'Oria F, Falcidia C, Foggi G, Bianco M, Cascio Ingurgio R, Alfano A, Ibba L, Valenti M, Costanzo A, Narcisi A, Gargiulo L
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.